119 related articles for article (PubMed ID: 38160571)
41. Spectrum of haematologic malignancies and survival outcomes of adult lymphomas in Maiduguri, north eastern Nigeria--a fourteen year review.
Kagu MB; Ahmed SG; Bukar AA; Mohammed AA; Mayun AA; Musa AB
Afr J Med Med Sci; 2013 Mar; 42(1):5-14. PubMed ID: 23909089
[TBL] [Abstract][Full Text] [Related]
42. Risk of disability pension for patients diagnosed with haematological malignancies: a register-based cohort study.
Horsboel TA; Nielsen CV; Andersen NT; Nielsen B; de Thurah A
Acta Oncol; 2014 Jun; 53(6):724-34. PubMed ID: 24456498
[TBL] [Abstract][Full Text] [Related]
43. A systematic review and meta-analysis of haematological malignancies in residents living near petrochemical facilities.
Jephcote C; Brown D; Verbeek T; Mah A
Environ Health; 2020 May; 19(1):53. PubMed ID: 32430062
[TBL] [Abstract][Full Text] [Related]
44. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
Passamonti F; Cattaneo C; Arcaini L; Bruna R; Cavo M; Merli F; Angelucci E; Krampera M; Cairoli R; Della Porta MG; Fracchiolla N; Ladetto M; Gambacorti Passerini C; Salvini M; Marchetti M; Lemoli R; Molteni A; Busca A; Cuneo A; Romano A; Giuliani N; Galimberti S; Corso A; Morotti A; Falini B; Billio A; Gherlinzoni F; Visani G; Tisi MC; Tafuri A; Tosi P; Lanza F; Massaia M; Turrini M; Ferrara F; Gurrieri C; Vallisa D; Martelli M; Derenzini E; Guarini A; Conconi A; Cuccaro A; Cudillo L; Russo D; Ciambelli F; Scattolin AM; Luppi M; Selleri C; Ortu La Barbera E; Ferrandina C; Di Renzo N; Olivieri A; Bocchia M; Gentile M; Marchesi F; Musto P; Federici AB; Candoni A; Venditti A; Fava C; Pinto A; Galieni P; Rigacci L; Armiento D; Pane F; Oberti M; Zappasodi P; Visco C; Franchi M; Grossi PA; Bertù L; Corrao G; Pagano L; Corradini P;
Lancet Haematol; 2020 Oct; 7(10):e737-e745. PubMed ID: 32798473
[TBL] [Abstract][Full Text] [Related]
45. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
46. [Population-based incidence of lymphoid neoplasms by histological subtypes in Girona (Spain), 1994-2001].
Marcos-Gragera R; Vilardell L; Izquierdo A; Masuet C; Gardella S; Bernado L; Sanjosé Sd; Moreno V
Med Clin (Barc); 2006 Jan; 126(1):5-12. PubMed ID: 16409944
[TBL] [Abstract][Full Text] [Related]
47. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
Franklin J; Eichenauer DA; Becker I; Monsef I; Engert A
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD008814. PubMed ID: 28901021
[TBL] [Abstract][Full Text] [Related]
48. Time and spatial trends in lymphoid leukemia and lymphoma incidence and survival among children and adolescents in Manitoba, Canada: 1984-2013.
Ye X; Torabi M; Lix LM; Mahmud SM
PLoS One; 2017; 12(4):e0175701. PubMed ID: 28430788
[TBL] [Abstract][Full Text] [Related]
49. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.
Essig S; Li Q; Chen Y; Hitzler J; Leisenring W; Greenberg M; Sklar C; Hudson MM; Armstrong GT; Krull KR; Neglia JP; Oeffinger KC; Robison LL; Kuehni CE; Yasui Y; Nathan PC
Lancet Oncol; 2014 Jul; 15(8):841-51. PubMed ID: 24954778
[TBL] [Abstract][Full Text] [Related]
50. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
51. Follow up of mortality and incidence of cancer 1952-98 in men from the UK who participated in the UK's atmospheric nuclear weapon tests and experimental programmes.
Muirhead CR; Bingham D; Haylock RG; O'Hagan JA; Goodill AA; Berridge GL; English MA; Hunter N; Kendall GM
Occup Environ Med; 2003 Mar; 60(3):165-72. PubMed ID: 12598662
[TBL] [Abstract][Full Text] [Related]
52. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
53. Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France.
Monnereau A; Troussard X; Belot A; Guizard AV; Woronoff AS; Bara S; Lapôtre-Ledoux B; Iwaz J; Tretarre B; Maynadié M;
Int J Cancer; 2013 May; 132(10):2378-87. PubMed ID: 23034773
[TBL] [Abstract][Full Text] [Related]
54. Gender and ethnic differences in incidence and survival of lymphoid neoplasm subtypes in an Asian population: Secular trends of a population-based cancer registry from 1998 to 2012.
Lim RB; Loy EY; Lim GH; Zheng H; Chow KY; Lim ST
Int J Cancer; 2015 Dec; 137(11):2674-87. PubMed ID: 26061168
[TBL] [Abstract][Full Text] [Related]
55. [Report on health status of residents in areas with industrial, mining or military sites in Sardinia, Italy].
Biggeri A; Lagazio C; Catelan D; Pirastu R; Casson F; Terracini B
Epidemiol Prev; 2006; 30(1 Suppl 1):5-95. PubMed ID: 16826748
[TBL] [Abstract][Full Text] [Related]
56. Epidemiology of lymphomas.
Roman E; Smith AG
Histopathology; 2011 Jan; 58(1):4-14. PubMed ID: 21261679
[TBL] [Abstract][Full Text] [Related]
57. Distribution pattern and prevalence of haematological cancers among adults in Abakaliki, South-Eastern Nigeria.
Ugwu NI; Okoye AE; Ugwu CN; Iyare FE; Edegbe FO; Ugwu GC; Chukwurah EF; Richard IC; John DO; Nnadozie UU; Nwokwu EU
Niger Postgrad Med J; 2021; 28(4):266-272. PubMed ID: 34850754
[TBL] [Abstract][Full Text] [Related]
58. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals.
Conrad N; Judge A; Tran J; Mohseni H; Hedgecott D; Crespillo AP; Allison M; Hemingway H; Cleland JG; McMurray JJV; Rahimi K
Lancet; 2018 Feb; 391(10120):572-580. PubMed ID: 29174292
[TBL] [Abstract][Full Text] [Related]
59. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
60. Pneumonia diagnosis in childhood and incidence of leukaemia, lymphoma and brain cancer: a Danish nationwide cohort study.
Søgaard KK; Farkas DK; Sørensen HT
BMJ Open; 2017 Dec; 7(12):e019860. PubMed ID: 29289943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
